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KIT constitutes the cell surface transmembrane receptor pro-
tein tyrosine kinase for a growth factor variously termed steel 
factor (SLF) , stem cell factor, mast cell growth factor, or Kit 
ligand. Inherited mutations of the KIT gene result in piebald-
ism in humans and dominant white spotting (W) in mice. 
Patches of hypopigmented skin and hair in these disorders 
represent regions lacking in melanocytes, the result of defec-
tive melanoblast differentiation, migration, proliferation, or 
T he KIT protein constitutes the cell surface transmem-brane receptor tyrosine kinase for a polypeptide growth factor variously termed steel factor (SLF), stem cell factor, mast cell growth factor, or Kit ligand (re-viewed in [1]) . Binding of SLF to the extracellular 
domain of the KIT receptor initiates a pathway of signal transduc-
tion that culminates ultimately in cell proliferation (reviewed in 
[2,3]) . The KIT gene was originally identified as the activated onco-
gene v-kit of the HZ-4 feline sarcoma virus [4] . However, KIT has 
assumed p~rhaps greater biologic significance as the gene responsi-
ble for piebaldism in humans and dominant white spotting (W) in 
mice (reviewed in [5 - 7]) . These two homologous disorders both 
result from KIT gene mutations that reduce KIT-mediated signal 
transduction. Human piebaldism and mouse dominant white spot-
ting are both characterized by congenital patches of white skin and 
hair that completely lack pigment, and electron microscopic analy-
ses have demonstrated the absence of melanocytes from these re-
gions of leukoderma [8,9]. Furthermore, grafting experiments have 
demonstrated that the defect in these disorders is intrinsic to the 
melanocyte [10,11]. Dermal melanocytes derive embryologically 
from the neural crest, and human piebaldism and mouse W have 
thus been considered to be lineage-specific disorders of neural crest 
development, possibly involving defective melanoblast differentia-
tion, proliferation, migration, or survival [10,12,13]. 
KIT mRNA and KIT receptor protein are expressed in human 
and murine melanocytes [14,15], and exogenous SLF activates a 
protein tyrosine phosphorylation cascade and induces proliferation 
of normal human melanocytes in culture [16] . Injection of neutral-
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survival during embryonic development. Here we show that 
incubation of n0fl11al human melanocytes with a KIT anti-
sense oligodeoxynucleotide greatly inhibits cell proliferation 
in culture, whereas incubation with a KIT sense oligodeoxy-
nucleotide has no effect. The KIT oligodeoxynucleotides 
also had little or no effect on cell survival. Key words: signal 
transduction/tyrosine kinase/growth factors/receptors.] Invest Der-
malol1 03: 148 -150, 1994 
izing anti-c-kit antibody into developing mouse embryos demon-
strated an apparent requirement for KIT-mediated signal transduc-
tion at day 14.5 post-COiUlI11, during proliferation of mesodermal 
melanoblasts and their migration to the ectoderm, and again post-
natally, for proliferation of skin melanocytes during the hair cycle 
[17]. Here, we describe the use of a KIT antisense oligodeoxynu-
c1eotide to inhibit the expression of KIT in normal cultured human 
melanocytes. Antisense oligodeoxynucleotides complementary to 
cellular mRNAs have been widely used to study the effects of inhib-
iting expression of specific proteins in cultured cells [18 -24]. We 
show th'l;t a human KIT antisense oligodeoxynucleotide dramati-
cally inhibits the proliferation of normal human melanocytes in 
culture, with little or no effect on cell survival. 
MATERIALS AND METHODS 
Cell Culture and Oligodeoxynucleotide Treatment Two comple-
mentary unmodified 21-mer oligodeoxynucleotides corresponding to either 
the sense (S'-ATGAGAGGCGCTCGCGGCGCC-3') or antisense (5'-
GGCGCCGCGAGCGCCTGTCAT-3') strands of human KIT mRNA 
beginning at the translational initiation codon [25] were synthesized and 
were applied to cultured normal human melanocytes without purification. 
Normal early-passage human cutaneous melanocytes were purchased from 
C lonetics and were cultured in melanocyte growth medium (MGM; Clone-
tics) without serum. Cells were ~eeded in 24-well plates at an initial cell 
number of 2 X 10' cells per well in 0.5 011 of media containing 10 Ilg of 
either the sense or antisense KIT oligodeoxynucleotides, or with no oligo-
deoxynuclcotide at all. The initial dose of oligodeoxynucleotide was supple-
mented with additional 5 Ilg doses after 24 and 48 h in culture, yielding a 
final dose of20 Ilg (40 Ilg/ml), and the culture media were supplemented by 
the addition of 0.2 011 of fresh MGM (without oligodeoxynucleotides) on 
day 8. On the fifth, eighth, and twelfth days after exposure to oligodeo>.]'-
nucleotides triplicate wells for each condition were harvested and counts of 
both viable and dead cells were performed by trypan blue exclusion on both 
the attached cells and the ce lls in the culture medium. Stability of the 
oligodeoxynucleotides was assayed by polyacrylamide gel electrophoresis of 
the 12-d culture media. The entire experiment was performed three times. 
Statistical analyses were performed using a modified form of Friedman's test 
(a nonparametric analysis of variance on ranks) [26] and a multiple compari-
son method, a very conservative approach. 
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Figure 1. Effect of KIT sense and antisense oligodeoxynucleotides on nor-
mal human melanocytes in culture. Vertical bars, totaI cells;gray shadi"g, dead 
cells. The entire experiment was performed three times; this figure illus-
trates the cell numbers averaged over the three independent experiments. 
Consistent differences in absolute cell number between experiments resulted 
in the large standard deviations indicated; however. within each experiment 
the difference in cell number in wells treated with the KIT antisense oligo-
deoxynucleotide versus the sense oligodeoxynucleotide was high ly signifi-
cant at the 1 % level. 
RESULTS AND DISCUSSION 
Oligodeoxynucleotides corresponding to the complementary 
"sense" and "antisense" strands of human KIT mRN A in the region 
of the translational initiation codon were used to test the effect of 
inhibiting KIT expression on proliferation of cultured normal 
human melanocytes. Polyacrylamide gel electrophoresis of the 12-d 
culture media demonstrated that both the sense and antisense oligo-
deoxynucleotides were stable and intact over the course of the ex-
periment, consistent with our experience with other oligodeoxynu-
cleo tides in serum-free culture medium [24J . We observed no 
apparent qualitative difference in the cellular morphology or degree 
of pigmentation among melanocyte cultures treated with no oligo-
deoxynucleotide or either the KIT sense or antisense oligodeoxynu-
cleotides, although these parameters were not scored quantitatively. 
However, we observed a significant reduction of total cell number 
in melanocyte cultures treated with the KIT anti-sense oligodeox-
ynucleotide. As shown in Fig 1, incubation of mclanocytes with the 
KIT sense oligodeoxynucleotide had no apparent effect on the rate 
of cell proliferation in culture. Averaged over the three experi-
ments, melanocytes treated with the KIT sense oligodeoxynucleo-
ride increased approximately 5.6-fold in number over 12 d in cul-
ture, as compared to an increase of about sixfold for untreated 
melanocytes; the difference between sense-treated and untreated 
cells was not statistically significant in any of the three experiments . 
In contrast, melanocytes treated with the KIT antisense oligodeox-
ynucleotide increased only by about 2.3-fold in number, on average. 
In each of the three experiments this difference was highly signifi-
cant at the 1 % level. 
The observed red uction of ultimate number of melanocytes in 
response to the KIT antisense oligodeoxynucleotide might result 
fro m decreased cell proliferation, increased cell death, or both. To 
distinguish between these alternatives, living and dead cells were 
scored differentially. As shown in Fig 1, although the fraction of 
dead cells was considerably greater in wells treated with the KIT 
antisense oligodeoxynucleotide, this primarily reflects the reduc-
tion in total cell number. In fact, the absolute number of dead cells 
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was approximately equa l in th e three conditions. and did not change 
significantly over the course of any of the experiments. This sug-
gests that the dead cells derived principall y from the relatively low 
plating efficiency of melanocytes in serum-free culture. Thus, the 
KIT antisense oligodeoxynucleotide appears to principally inhibit 
proliferation of melanocytes in culture, rather than cell survival. 
This is consistent with the fact that humans with piebaldism and W 
mutant mice do not become progressively more hypopigmented; on 
the contrary, some filling-in of hypopi gmented regions may occur 
over time. 
Although the requirement of KIT function for melanocyte pro-
liferation is not unexpected, it may at first seem surprising that this 
requirement was observed in serum-free culture, in the absence of 
exogenous SLF, which is not a component of MGM. However, the 
predominant isoform of KIT mRNA and receptor protein in human 
melanocytes [27J , so-called KIT + [28J, in the absence of exogenous 
SLF exhibits a low level of constitutive tyrosine phosphorylation 
and association with phosphatidylinositol 3'-kinase and phospholi-
pase C-y1 [28]. two of the distal components in the KIT-mediated 
signal-transduction pathway (16,28 -30J. Reduced expression of 
this predominant KIT receptor isoform by melanocytes treated with 
the KIT antisense oligodeoxynucleotide would th erefore decrease 
this low level of constitutive KIT-mediated signal transduction, 
resulting in a reduced rate of cell proliferation even in the absence of 
exogenous SLF. 
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